Dr. Lal Path Labs Ltd. — Investor Meet, 03-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

**Financial Performance:** Dr. Lal PathLabs reported Q3 FY25 revenue of Rs.597 crore, up 10.7% YoY from Rs.539 crore. Year-to-date revenue reached Rs.1,859 crore, marking a 10.6% increase. Q3 FY25's EBITDA rose 9.6% YoY to Rs.154 crore, with a margin of 25.8%. Profit Before Tax (PBT) and Profit After Tax (PAT) also saw significant gains, with PBT at Rs.138 crore (up 19.4%) and PAT at Rs.98 crore (up 19.3%).

**Future Outlook and Growth Drivers:** Management emphasized expanding operations in Tier-2 and Tier-3 markets, with plans to open 15-20 new labs this fiscal year. The Swasthfit program continues to show robust performance, growing 27.2% in Q3 FY25, which indicates ongoing strength in bundled testing offerings.

**Order Book and Operational Updates:** The company maintained a sample volume growth of 10.3% YoY with 20.6 million samples processed in Q3. Patient volumes grew by 3.8%, reflecting increased operational capacity and strategic geographic focus.

**Analyst Q&A Insights:** Analysts inquired about gross margins and operational efficiency. Management indicated stable margins despite raw material price pressures, due to strategic mix management and cost controls. Employee costs have risen due to infrastructure investments and a growing sales team, expected to stabilize as new hires mature. Analysts also explored market dynamics, with management confident in navigating competitive pressures without compromising pricing strategy.

**Strategic Focus Areas:** Key areas of focus include enhancing digital capabilities and expanding diagnostic services, particularly in molecular and genomic testing. Management remains committed to maintaining high standards in quality while optimizing operational efficiency across markets.

**Investor Insight:** The company's strong growth trajectory and strategic initiatives, coupled with improving profitability metrics, position Dr. Lal PathLabs as a compelling investment opportunity, suggesting potential for a 'buy' stance. Continued focus on expanding market reach and service offerings will likely drive future growth and shareholder value.